Trials / Completed
CompletedNCT04984200
Assessment of EyeArt Performance With Retinal Cameras
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 246 (actual)
- Sponsor
- Eyenuk, Inc. · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
The study evaluates the performance of the EyeArt system for detecting diabetic retinopathy from images captured using retinal cameras and operators.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Retinal imaging | Subjects will undergo retinal imaging before and/or after administration of mydriatic agent |
| DRUG | Mydriatic Agent | Subjects will be administered mydriatic medication to dilate their pupils. |
Timeline
- Start date
- 2021-07-13
- Primary completion
- 2022-08-19
- Completion
- 2022-08-19
- First posted
- 2021-07-30
- Last updated
- 2022-11-09
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04984200. Inclusion in this directory is not an endorsement.